InvestorsHub Logo
Followers 28
Posts 4385
Boards Moderated 1
Alias Born 09/22/2006

Re: DewDiligence post# 1307

Saturday, 07/14/2007 12:33:05 PM

Saturday, July 14, 2007 12:33:05 PM

Post# of 3757
Cash on hand...
According to TheStreet.com:
>>Despite the discontinuation of the development of valopicitabine, the company said it still expects to end 2007 with $100 million to $110 million of cash, cash equivalents and marketable securities.<<
Divide that by 60m and you get less than $2 per share. Dew: what am I missing?
Thanks,
Fred

The more you know, the less you don't know.